Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers

Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers

Bibliographic Details
Main Authors:	Maya H Buch, Sven Plein, Graham Fent, Bara Erhayiem, Lesley-Anne Bissell, Francesco Del Galdo, Giuseppina Abignano, Dominik Schlosshan, Agata Burska, Ananth Kidambi, Raluca B Dumitru, Ana-Maria H Dumitru, Helena Donica, John Biglands
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/7/3/e001689.full

Similar Items

Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change
by: Raluca B. Dumitru, et al.
Published: (2023-02-01)

Using cardiovascular magnetic resonance to define mechanisms of comorbidity and to measure the effect of biological therapy: the CADERA observational study
by: Sven Plein, et al.
Published: (2021-03-01)

A comparison of cardiovascular magnetic resonance and single photon emission computed tomography (SPECT) perfusion imaging in left main stem or equivalent coronary artery disease: a CE-MARC substudy
by: James R. J. Foley, et al.
Published: (2017-11-01)

Biomarkers as an opportunity to stratify for outcome in systemic sclerosis
by: Giuseppina Abignano, et al.
Published: (2020-10-01)

Clinical Application of Dynamic Contrast Enhanced Perfusion Imaging by Cardiovascular Magnetic Resonance
by: Russell Franks, et al.
Published: (2021-10-01)

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
by: Lylia Ouboussad, et al.
Published: (2019-03-01)

Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy
by: Korpysz Maciej, et al.
Published: (2014-09-01)

Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes
by: Peter P. Swoboda, et al.
Published: (2018-03-01)

Cardiovascular magnetic resonance stress perfusion compared to single-photon emission computed tomography (SPECT) in patients with left main stem disease: a CE-MARC substudy
by: Greenwood John P, et al.
Published: (2012-02-01)

SLEEP DURATION AND CARDIOVASCULAR RISK
by: Mihaela Daniela Baltă, et al.
Published: (2018-09-01)

Serum leptin concentration in patients with type 2 diabetes
by: Malecha-Jedraszek Arleta, et al.
Published: (2015-12-01)

Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance
by: Ball Stephen G, et al.
Published: (2010-11-01)

Robust myocardial T2 and T2* mapping at 3T
by: Zaman Arshad, et al.
Published: (2012-02-01)

Visualization of coronary venous anatomy by cardiovascular magnetic resonance
by: Crean Andrew, et al.
Published: (2009-08-01)

Influence of peri-infarct dysglycaemia on myocardial infarct size and its effect on cardiovascular outcome as determined by cardiovascular magnetic resonance imaging
by: Ball Stephen G, et al.
Published: (2010-01-01)

The assessment of reperfusion haemorrhage following acute myocardial infarction by T2 and T2* cardiovascular magnetic resonance
by: Greenwood John P, et al.
Published: (2010-01-01)

Statistical Study Regarding the Presence of Gram Bacteria in Patients with Cardiovascular Disease and Periodontal Disease
by: Ioana VOINESCU, et al.
Published: (2021-12-01)

Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review
by: Sindhoora Kotha, et al.
Published: (2024-03-01)

Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition
by: Clarissa Corinaldesi, et al.
Published: (2021-03-01)

Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
by: A Malecha-Jędraszek, et al.
Published: (2011-04-01)

Impact of coronary artery tortuosity in ischemic and non-ischemic cardiovascular pathology
by: Mihai Dumitru Emilian, et al.
Published: (2021-06-01)

CARDIOVASCULAR DISEASE MANAGEMENT IN A PATIENT WITH CHRONIC KIDNEY DISEASE IN PRIMARY CARE
by: Mihaela Daniela Baltă, et al.
Published: (2018-03-01)

First-pass myocardial perfusion assessment using eight-fold accelerated k-t BLAST stress DCE-MRI with rapid parametric mapping
by: Biglands John, et al.
Published: (2009-01-01)

Characterisation of haemodynamic and vascular dysfunction in bicuspid aortic valve disease using advanced cardiovascular magnetic resonance imaging techniques
by: Bissell, MM
Published: (2015)

The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis
by: Gianluca Bagnato, et al.
Published: (2021-03-01)

Left ventricular blood flow kinetic energy after myocardial infarction - insights from 4D flow cardiovascular magnetic resonance
by: Pankaj Garg, et al.
Published: (2018-08-01)

Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance
by: Vanessa M. Ferreira, et al.
Published: (2023-03-01)

30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper
by: Subha V. Raman, et al.
Published: (2022-03-01)

Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects
by: Louise A. E. Brown, et al.
Published: (2018-07-01)

Update of the European Association of Cardiovascular Imaging (EACVI) Core Syllabus for the European Cardiovascular Magnetic Resonance Certification Exam.
by: Petersen, SE, et al.
Published: (2014)

Assessment of myocardial infarct size and left ventricular function following acute myocardial infarction by cardiovascular magnetic resonance: A comparison of treatment with thrombolysis versus primary percutaneous coronary intervention
by: Ball Stephen G, et al.
Published: (2010-01-01)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
by: Adam K. McDiarmid, et al.
Published: (2020-01-01)

Secondary mitral regurgitation: reducing the leak, expanding the science
by: Sam Straw, et al.
Published: (2020-12-01)

Reciprocal ECG change in ST-elevation myocardial infarction is associated with area at risk and myocardial salvage following revascularization
by: Kidambi Ananth, et al.
Published: (2013-01-01)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
by: Pankaj Garg, et al.
Published: (2022-06-01)

Molecular Research in Cardiovascular Disease
by: Maria Dorobantu, et al.
Published: (2021-07-01)

The Liver and the Cardiovascular System: Two of a Kind?
by: Sven Francque
Published: (2021-04-01)

Analysis of Medical Tourism for Cardiovascular Diseases
by: Catalina Liliana Andrei, et al.
Published: (2014-11-01)

A case report of primary meningococcal pericarditis secondary to Neisseria meningitidis in a young female patient
by: Matthew Green, et al.
Published: (2022-01-01)

Myocardial blood flow in patients withType 2 Diabetes Mellitus and normal coronary angiography
by: Radjenovic Aleksandra, et al.
Published: (2011-02-01)